#DeSci OG. Our ꧁BioIP꧂ protocol empowers Families & Individuals to establish Ownership & Control over their DNA 🧬 data. Genomics MCP Server. Techstars '24.
https://t.co/maNygr0LOB at the @GA4GH Passport Hackathon: we demonstrated a GA4GH Passport visa as a revocable, patient-owned BioNFT on a public blockchain. The patient holds the permission and can revoke it. Consent you can take back. 🧬 https://t.co/9rZzNS4kOt
Cloudflare Wallets just brought x402 to AI agents.
Paying to read a genome isn't enough. You need consent.
https://t.co/Wv9at6SP0U shipped both: an x402 request settles USDC, verifies ERC-8356 consent, then runs a GPU variant-caller.
https://t.co/Q5Cd0qYtVX
Happy to open ERC-8356 from https://t.co/Wv9at6SP0U 🧬
Purpose-bound consent: subject is not the beneficiary. Withdrawal at access time. BioNFTs + BioFS: every act is a legal act.
https://t.co/6xeVLYr2Un
Happy to open ERC-8356 from https://t.co/Wv9at6SP0U 🧬
Purpose-bound consent where the subject is not the beneficiary. Withdrawal at access time. BioNFTs + BioFS: every act is a legal act. Built for biobanking after the GA4GH AAI gap.
Whitepaper: https://t.co/6xeVLYr2Un
This is HIPAA, GDPR, and CCPA compliance by code, not by promise. Patients lease their genome to AI on their terms, get paid, and can revoke anytime. Lease your genome to the agent. Don't lose it. Full piece: https://t.co/HtB9PUJFDH
"Upload your DNA, get an AI report." That pattern is a HIPAA time bomb. Agentic AI is arriving in healthcare, EMR, and genomics, and policy promises won't protect PHI. Compliance has to be enforced by code. Here's how.
The pattern: every AI call gated by a BioNFT (revocable consent). PHI stays in encrypted storage, read through BioFS and biofs-node with Bloom-filter access control. The x402 biorouter meters and audits each call on chain. The data is leased, never copied.
Biodata is among the most valuable training data in the world.
Built on Story, @genobank_io enables breast cancer patients in Mexico to classify their DNA, detect risks early, and license their data for revenue.
This is what patient-owned medicine looks like.
Les patients peuvent désormais posséder et monétiser leurs données génomiques.
https://t.co/I7cePZUto6
@genobank_io permet aux patientes atteintes du cancer du sein au Mexique de classifier leur ADN, détecter les risques tôt et licencier leurs données pour générer des revenus.
Big news The first Bio patent has landed on Verio
Patented BioNFTs™ (US-11984203-B1, US-11915808-B1) by @genobank_io now make it possible to certify ownership of genomic data in VCF files.
From DNA → IP, we’re entering a new era of data sovereignty where individuals can truly own, control, share, and even be rewarded for their genetic data.
This isn’t just about technology. It’s about reshaping the way humanity thinks about genomics, privacy, and value creation in the age of AI and bioinformatics.
By staking on the first BioIP @StoryProtocol, you’re not just earning yield you’re endorsing the legitimacy of this breakthrough patent and supporting ethical, transparent, and compliant data sharing.
The future of genomic ownership is here. And it starts on @verio_story@mushy@0xbunny_@ICat4you@BharatWormie
Origin Summit is almost here and the lineup is getting even bigger:
➤ Sreeram Kannan @SreeramKannan, Founder and CEO, EigenLayer
➤ Guy Young @gdog97_, Founder, Ethena
➤ Simon Kim @simonkim_nft, CEO & Managing Partner, Hashed
The first ever Bio patent has officially gone on-chain 🧬
Patented BioNFTs™ from @genobank_io are now stakable on @StoryProtocol turning DNA into IP.
A massive step for genomic data sovereignty, where people can finally own, share, and be rewarded for their genetics🚀🚀
🙏 Merci @StoryFrance pour votre soutien exceptionnel !
Grâce à @StoryProtocol, les patients peuvent enfin posséder et monétiser leurs données génomiques 🧬
📍 https://t.co/r1ZxtjsE66
🇲🇽🌍 Nos patientes au Mexique et dans le monde peuvent maintenant :
✅ Classifier leur ADN
✅ Détecter les risques précocement
✅ Licencier leurs données
L’innovation blockchain au service de la santé mondiale !
Les patients peuvent désormais posséder et monétiser leurs données génomiques.
https://t.co/I7cePZUto6
@genobank_io permet aux patientes atteintes du cancer du sein au Mexique de classifier leur ADN, détecter les risques tôt et licencier leurs données pour générer des revenus.